title: Acute rhabdomyolysis after atorvastatin and fusidic acid therapy.
authors.forename: C
authors.initials: C
authors.lastname: Wenisch
authors.forename: R
authors.initials: R
authors.lastname: Krause
authors.forename: P
authors.initials: P
authors.lastname: Fladerer
authors.forename: I
authors.initials: I
authors.lastname: El Menjawi
authors.forename: E
authors.initials: E
authors.lastname: Pohanka
mesh_terms: D000208:Acute Disease; D000368:Aged; D000800:Angioplasty, Balloon / Q000009:adverse effects; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D001157:Arterial Occlusive Diseases / Q000628:therapy; D000069059:Atorvastatin; D004359:Drug Therapy, Combination; D005672:Fusidic Acid / Q000009:adverse effects*; D006538:Heptanoic Acids / Q000009:adverse effects*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects*; D006949:Hyperlipidemias / Q000188:drug therapy; D008297:Male; D011758:Pyrroles / Q000009:adverse effects*; D012206:Rhabdomyolysis / Q000139:chemically induced*; D012307:Risk Factors; D013530:Surgical Wound Infection / Q000188:drug therapy / Q000209:etiology; D016909:Tibial Arteries
chemical_list: D000900:Anti-Bacterial Agents; D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011758:Pyrroles; D005672:Fusidic Acid; D000069059:Atorvastatin